Stock Analysis

Insider-Favored Growth Companies Including Sri Trang Agro-Industry

SET:STA
Source: Shutterstock

Amid recent market fluctuations driven by tariff uncertainties and mixed economic indicators, investors are increasingly focused on identifying growth opportunities that may offer resilience in a volatile environment. Companies with high insider ownership often signal confidence from those with intimate knowledge of the business, making them attractive candidates for investors seeking to navigate these challenging conditions.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3)17.3%22.8%
Clinuvel Pharmaceuticals (ASX:CUV)10.4%26.2%
SKS Technologies Group (ASX:SKS)29.7%24.8%
Propel Holdings (TSX:PRL)36.5%38.7%
CD Projekt (WSE:CDR)29.7%39.4%
On Holding (NYSE:ONON)19.1%29.7%
Pharma Mar (BME:PHM)11.9%44.7%
Kingstone Companies (NasdaqCM:KINS)20.8%24.9%
Elliptic Laboratories (OB:ELABS)26.8%121.1%
Findi (ASX:FND)35.8%111.4%

Click here to see the full list of 1451 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Sri Trang Agro-Industry (SET:STA)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sri Trang Agro-Industry Public Company Limited, along with its subsidiaries, operates in the manufacturing and distribution of natural rubber products across Thailand, China, the United States, Singapore, Japan and internationally with a market cap of approximately THB22.43 billion.

Operations: The company's revenue segments include Gloves at THB23.30 billion and Natural Rubbers at THB86.85 billion.

Insider Ownership: 21.6%

Revenue Growth Forecast: 11.8% p.a.

Sri Trang Agro-Industry is experiencing significant earnings growth, forecasted at 58.1% annually, outpacing the Thai market's 16.4%. However, revenue growth of 11.8% remains below the desired 20%, and profit margins have declined from last year. The recent fixed-income offering with debentures due in 2028 may impact financial flexibility. Insider trading data is limited for the past three months, and dividends are not well covered by earnings or cash flow.

SET:STA Ownership Breakdown as at Feb 2025
SET:STA Ownership Breakdown as at Feb 2025

GENDA (TSE:9166)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: GENDA Inc. operates amusement arcades primarily under the GiGO brand in Japan, with a market cap of ¥226.31 billion.

Operations: The company's revenue is derived from two main segments: Entertainment Content, contributing ¥12.28 billion, and Entertainment Platform, generating ¥85.01 billion.

Insider Ownership: 21.4%

Revenue Growth Forecast: 11.8% p.a.

GENDA is forecasted to achieve significant earnings growth of 20.6% annually, surpassing the JP market's 7.7%, while revenue is expected to grow at 11.8% per year, faster than the market average but below a high-growth threshold. Despite strong growth prospects, profit margins have halved over the past year and debt coverage by operating cash flow remains inadequate. Insider trading data for recent months is unavailable, and share price volatility has been high recently.

TSE:9166 Earnings and Revenue Growth as at Feb 2025
TSE:9166 Earnings and Revenue Growth as at Feb 2025

Panjit International (TWSE:2481)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Panjit International Inc. is involved in the manufacturing, processing, assembling, importing, and exporting of semiconductors across various countries including Taiwan, China, Korea, the United States, Japan, Germany, and Italy with a market cap of NT$18.70 billion.

Operations: The company's revenue is primarily derived from Power Split Components at NT$11.40 billion, followed by Power Integrated Circuits and Components at NT$943.64 million, and Solar at NT$220.88 million.

Insider Ownership: 10.1%

Revenue Growth Forecast: 13.2% p.a.

Panjit International's earnings are projected to grow significantly at 30.3% annually, outpacing the Taiwan market's 17.8%. Revenue growth is also expected to exceed the market average, though not at a high-growth rate. The price-to-earnings ratio of 22.7x suggests better value compared to industry peers. However, dividend sustainability is questionable as it isn't well covered by free cash flows, and insider trading data for recent months is unavailable.

TWSE:2481 Earnings and Revenue Growth as at Feb 2025
TWSE:2481 Earnings and Revenue Growth as at Feb 2025

Seize The Opportunity

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SET:STA

Sri Trang Agro-Industry

Manufactures and distributes natural rubber products in Thailand, China, the United States, Singapore, Japan, and internationally.

Reasonable growth potential slight.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.11% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|23.535% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor